Present status of therapeutic apheresis in Japan: survey report. (Survey Subcommittee, Scientific Committee, Japanese Society for Apheresis).
Shimizu
M
M
Tokyo Women's Medical College, Japan.
Tsuda
H
H
Sanaka
T
T
Ide
K
K
D000925:Anticoagulants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000628:therapy; D001172:Arthritis, Rheumatoid / Q000628:therapy; D001698:Biomedical Engineering; D001781:Blood Component Removal / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data*; D002423:Cause of Death; D003093:Colitis, Ulcerative / Q000628:therapy; D003711:Demyelinating Diseases / Q000628:therapy; D006505:Hepatitis / Q000628:therapy; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000628:therapy; D007564:Japan / Q000453:epidemiology; D017093:Liver Failure / Q000628:therapy; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D009157:Myasthenia Gravis / Q000628:therapy; D009726:Nurses; D010820:Physicians; D010949:Plasma; D011041:Poisoning / Q000628:therapy; D011129:Polyradiculoneuropathy / Q000628:therapy; D012709:Serum Albumin / Q000627:therapeutic use; D012772:Shock, Septic / Q000628:therapy; D013997:Time Factors
D000925:Anticoagulants; D012709:Serum Albumin